Dr. Porubcin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Genesis Cancer Care Institute
1351 West Central Park Ave.
Davenport, IA 52804Phone+1 563-421-1900Fax+1 563-421-1809- Is this information wrong?
Summary
- Dr. Michael Porubcin is Board Certified Hematologist/Oncologist. He received his medical degree from Comenius University in 1986. After beeing in private practice for nearly 20 years, he has joined Genesis Cancer Care Institute in Davenport, IA.
Education & Training
University of South AlabamaFellowship, Hematology and Medical Oncology, 1996 - 1999- USA HealthResidency, Internal Medicine, 1993 - 1996
Memorial Sloan Kettering Cancer CenterBasic Science Research, Cell Biology and Genetics Department, 1992 - 1993- Memorial Sloan Kettering Cancer CenterBasic Science Research, Molecular Pharmacology & Chemistry Dept., 1991 - 1992
Comenius UniversityClass of 1986
Certifications & Licensure
IL State Medical License 1999 - 2026
IA State Medical License 2011 - 2025
CO State Medical License 1998 - 2017
AL State Medical License Active through 2016- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- The Mammadi Soudavar Memorial Fellowship, Memorial Sloan-Kettering Cancer Center in New York, NY The New York Community Trust, 1992
Publications & Presentations
PubMed
- 255 citationsDMT1: A mammalian transporter for multiple metalsMichael D. Garrick, Kevin G. Dolan, Craig Horbinski, Andrew J. Ghio, Dennis Higgins, Michael Porubcin, Elizabeth G. Moore, Lucille N. Hainsworth, Jay N. Umbreit, Marce...> ;Biometals. 2003 Mar 1
- 99 citationsSeparate pathways for cellular uptake of ferric and ferrous ironMarcel E. Conrad, Jay N. Umbreit, Elizabeth G. Moore, Lucille N. Hainsworth, Michael Porubcin, Marcia J. Simovich, Marian T. Nakada, Kevin G. Dolan, Michael D. Garrick> ;American Journal of Physiology. Gastrointestinal and Liver Physiology. 2000 Oct 1
- Human neuroblastoma I-type cells are malignant neural crest stem cells.Ross, R. A., Spengler, B. A., Domènech, C., Porubcin, M., Rettig, W. J., Biedler, J. L.> ;Cell Growth Differ. 1995 Apr
- Join now to see all
Journal Articles
- Factors predicting coronary artery disease in patients with giant negative T waves.Otrusinik R, Alpert MA, Hamm CR, Bikkina M, Porubcin M, Panayiotou H, Am J Cardiol., 85(7):873-5, A9, 4/1/2000
Abstracts/Posters
- Pretreatment of colon carcinoma cells to D1694 (Tomudex) markedly enhances 5-fluorouracil cytotoxicity. Proc. Amer. Cancer Res. 35:330, 1994.Chang YM, Zielinski Z, Izzo J, Porubcin M, Bertino JR, Proc. Amer. Cancer Res. 35:330, San Francisco, CA, 4/11/1994
- Rapid Elimination of P-glycoprotein-encoding Genes After Exposure of Vincristine-resistant Chinese Hamster Lunc Gells, DC-3F/VCR-5L, to Verapamil. Gen. Motors Cancer R...Biedler JL, Chang TD, Druskin H, Meyers MB, Porubcin M, Spengler BA, Gen. Motors Cancer Res. Found. Int. Symp., Toronto, Canada, 5/7/1993
- Sensitivity of Two Fluorouracil Resistant HCT-8 cell Lines to Fluorouridine (FUR), Methotrexate (MTX) and D1694, a Folate Inhibitor of Thymidylate Synthase. 33:543, 1...Chang YM, Aschele CS, Porubcin M, Bertino JR, Proc. Amer. Cancer Res., San Diego, CA, 5/21/1992
Press Mentions
Genesis Unveils Enhancements to Cancer Care in the Quad CitiesMarch 14th, 2019
Committees
- Chair, Cancer Committee 2019 - 2020
Professional Memberships
- Member
- Member
- Member
- Intl. Assoc. for the Study of Lung Cancer (IASLC)Member
- Catholic Medical Association (CMA)Member
Other Languages
- Czech
Hospital Affiliations
- Genesis Medical Center, SilvisSilvis, Illinois
- Genesis Medical Center - DavenportDavenport, Iowa
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
